March 21 2019 / TheNewswire / On this edition of NewlyTrading, Dr. Ernest Wong, CEO of NervGen Pharma Corp. (TSX.V:NGEN).

Dr. Wong speaks with host Jim Ripley about the company’s new life-changing nerve regeneration technology.

.

 

.

 

For further information, please contact Bill Radvak at (778) 888-4101 or via email: bradvak@nervgen.com  

 

Advisory Regarding Forward Looking Statements

This Podcast contains forward-looking statements. Users of forward-looking statements are cautioned that actual results may vary from forward-looking statements contained herein. Forward-looking statements include, but are not limited to: expectations, opinions, forecasts, projections and other similar statements concerning anticipated future events, conditions or results that are not historical facts. In certain cases, forward-looking statements can be identified by the use of words such as "plans", "expects" or "does not expect", "is expected", "budget", "scheduled", "estimates", "forecasts", "intends", "anticipates" or "does not anticipate", or "believes", or variations of such words and phrases or statements that certain actions, events or results "may", "could", "would", "might" or "will be taken", "occur" or "be achieved". While the Company has based these forward-looking statements on its expectations about future events as at the date those statements were prepared, the statements are not a guarantee of the Company's future performance. Although the Company believes that the expectations reflected in such forward-looking statements are reasonable, it cannot give any assurance that such expectations will prove to be correct.